Welcome to our dedicated page for HEALTHCARE SERVICES GROUP SEC filings (Ticker: HCSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HEALTHCARE SERVICES GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HEALTHCARE SERVICES GROUP's regulatory disclosures and financial reporting.
Healthcare Services Group Inc. executive Andrew Kush, EVP & Chief Operating Officer, reported a sale of 15,598 shares of common stock on 2026-08-04 at a weighted average price of $23.24 per share in an open-market or private transaction. Following this sale, he directly holds 22,741 shares of common stock. A footnote explains the sale was executed in multiple trades and that the reported price is a weighted average; detailed trade‑level prices and share amounts are available upon request. The Form 4 indicates the transaction was not made under a Rule 10b5-1 trading plan.
A stockholder of Healthcare Services Group, Inc. (HCSG) has notified of a potential sale of up to 15,598 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an aggregate market value of $362,452.23 as of the notice.
The shares consist of 2,278 performance shares dated February 24, 2025, 515 shares from an Employee Stock Purchase Plan dated December 31, 2021, and 12,805 restricted shares dated January 3, 2015. Sales may begin on or after August 4, 2026.
Healthcare Services Group, Inc. provides housekeeping, laundry, maintenance and dietary services to long-term care and other healthcare facilities across the U.S. For the quarter ended June 30, 2026, revenues rose to about $470.8 million from $458.5 million a year earlier, and net income was $22.7 million versus a prior-year loss of $32.4 million. For the first six months of 2026, revenue reached $933.6 million with net income of $48.8 million, compared with a $15.1 million loss in the first half of 2025, helped by much lower bad debt expense and higher investment income.
Operating cash flow for the six months was $65.6 million, supporting cash and cash equivalents of $123.4 million and total assets of $820.9 million. Environmental Services contributed about 45% of year-to-date revenue and Dietary about 55%. The allowance for doubtful accounts on accounts and notes receivable totaled $150.2 million, including full reserves on receivables from Genesis Healthcare. The company recorded a $12.3 million deferred Employee Retention Credit liability pending greater assurance, completed a 2026 acquisition adding $6.0 million of goodwill and $7.6 million of intangibles, and spent $44.9 million repurchasing shares, with 68,632,202 common shares outstanding as of July 22, 2026.
Healthcare Services Group reported second quarter 2026 revenue of $470.8 million, with Environmental Services contributing $213.2 million at a 13.3% margin and Dietary Services $257.6 million at a 7.5% margin. Cost of services was 84.1% of revenue, and SG&A was $52.6 million, or 9.7% after adjusting for deferred compensation.
Net income for the quarter was $22.7 million, compared with a net loss of $32.4 million a year earlier, and diluted EPS improved to $0.32 from $(0.44). Adjusted EBITDA reached $35.6 million, or 7.6% of revenue. Cash from operations was $21.9 million, or $27.9 million excluding the payroll accrual change.
At quarter end, the company held $200.9 million in cash and marketable securities and had an unutilized $300.0 million credit facility. It repurchased $20.9 million of stock in the quarter, $44.9 million year-to-date, and reaffirmed its 2026 mid-single-digit growth outlook.
Brophy Andrew M reported acquisition or exercise transactions in this Form 4 filing.
Healthcare Services Group Inc. reported that SVP & Chief Accounting Officer Andrew M. Brophy received a grant of 4,381 shares of Common Stock in the form of restricted stock units at no cash cost per share. These restricted stock units will vest at a rate of 20% each year, starting on the first anniversary of the July 1, 2026 grant date. Following this award, Brophy holds 19,922 unvested restricted stock units in total, which represent equity-based compensation rather than open-market share purchases.
HEALTHCARE SERVICES GROUP INC director Laura K. Grant received a compensatory stock award rather than making an open-market trade. On this Form 4, she acquired 306 shares of common stock on June 30, 2026 at a reference price of $24.56 per share as a grant or award.
Grant has elected to receive fully vested Deferred Stock Units (DSUs) under the company’s 2020 Amended Omnibus Incentive Plan instead of cash fees for serving on the Board and its committees. The number of DSUs is based on her fees divided by the issuer’s closing stock price on the payment date, rounded up to the nearest whole share.
After this grant, she directly holds 18,314 shares, consisting of 1,969 unvested DSUs and 16,345 vested DSUs. The DSUs will be settled in shares of common stock 90 days after she leaves the Board, and she may elect an additional deferral in line with Code Section 409A rules.
Healthcare Services Group Inc. director Thomas Gerard Whalen acquired 102 shares-equivalent of common stock on a grant basis valued at $24.56 per unit. He elected to receive fully vested Deferred Stock Units (DSUs) instead of cash board fees under the 2020 Omnibus Incentive Plan. Following this award, he holds 5,357 DSUs in total, consisting of 1,969 unvested and 3,388 vested units. These DSUs will be settled in common shares ninety days after he leaves the Board, subject to any further deferral election.
Simmons Kurt JR reported acquisition or exercise transactions in this Form 4 filing.
Healthcare Services Group Inc. director Kurt JR Simmons reported a compensation-related stock grant. He received 611 shares of common stock at $24.56 per share as a grant or award, bringing his direct holdings to 30,770 shares.
According to the disclosure, Simmons has elected to receive fully vested Deferred Stock Units instead of cash fees for his board and committee service under the 2020 Omnibus Incentive Plan. These DSUs will be settled in common shares on the earlier of January 1, 2031, his death, disability, separation from service, or a Change of Control, with the option to defer further under Code Section 409A.
HEALTHCARE SERVICES GROUP INC reports that EVP & Chief Financial Officer Vikas Singh exercised and vested 2,202 Restricted Stock Units from a May 27, 2025 grant, converting them into an equal number of common shares on May 27, 2026.
In connection with this vesting, 935 shares of common stock were withheld to satisfy tax obligations. After these transactions, he directly holds 3,347 shares of common stock.
HEALTHCARE SERVICES GROUP INC director Thomas Gerard Whalen reported a stock-based compensation grant rather than an open‑market trade. On May 26, 2026, he acquired 1,969 shares of Common Stock as fully vested Deferred Stock Units in lieu of cash board fees at a reference price of $20.32 per share.
After this grant, Whalen directly holds 5,255 shares, consisting of 4,775 unvested DSUs and 480 vested DSUs